Results

Veru Inc.

06/10/2021 | Press release | Distributed by Public on 06/10/2021 06:37

Veru Enrolls First Patient in Phase 2 Clinical Trial of VERU-100, Novel Long-acting GnRH Antagonist Decapeptide Injection Formulation, for the Treatment of Hormone Sensitive[...]